Hostname: page-component-848d4c4894-4hhp2 Total loading time: 0 Render date: 2024-06-12T03:34:55.389Z Has data issue: false hasContentIssue false
  • English
  • Français

Infection prevention and control practices related to carbapenemase-producing Enterobacteriaceae (CPE) in acute-care hospitals in Ontario, Canada

Published online by Cambridge University Press:  27 June 2019

Alainna J. Jamal ,
Felipe Garcia-Jeldes ,
Mahin Baqi ,
Sergio Borgia ,
Jennie Johnstone ,
Kevin Katz ,
Philipp Kohler ,
Matthew P. Muller ,
Allison J. McGeer  and
for the CPE Investigators of the Toronto Invasive Bacterial Diseases Network
Alainna J. Jamal
Affiliation:
Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada Department of Infection Control, Sinai Health System, Toronto, Ontario, Canada
Felipe Garcia-Jeldes
Affiliation:
Department of Infection Control, Sinai Health System, Toronto, Ontario, Canada
Mahin Baqi
Affiliation:
Department of Infection Prevention and Control, William Osler Health Center, Brampton, Ontario, Canada
Sergio Borgia
Affiliation:
Department of Infection Prevention and Control, William Osler Health Center, Brampton, Ontario, Canada
Jennie Johnstone
Affiliation:
Department of Infection Control, Sinai Health System, Toronto, Ontario, Canada Department of Infection Prevention and Control, Public Health Ontario, Toronto, Ontario, Canada
Kevin Katz
Affiliation:
Department of Infection Prevention and Control, North York General Hospital, Toronto, Ontario, Canada
Philipp Kohler
Affiliation:
Department of Infection Control, Sinai Health System, Toronto, Ontario, Canada
Matthew P. Muller
Affiliation:
Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada Department of Infection Prevention and Control, St Michael’s Hospital, Toronto, Ontario, Canada
Allison J. McGeer*
Affiliation:
Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada Department of Infection Control, Sinai Health System, Toronto, Ontario, Canada
for the CPE Investigators of the Toronto Invasive Bacterial Diseases Network
Affiliation:
Other members of the CPE Investigators of the Toronto Invasive Bacterial Diseases Network: Huda Al-Morhi, MD, LifeLabs, Toronto, Ontario, Canada; David Richardson, MD, William Osler Health Center, Brampton, Ontario, Canada; Brenda Coleman, PhD, Susan Poutanen, MD, MPH, and Cheryl Volling, MD, Sinai Health System, Toronto, Ontario, Canada; Roberto Melano, PhD and Samir Patel, PhD, Public Health Ontario, Toronto, Ontario, Canada; Jeff Powis, MD, Toronto East Health Network, Ontario, Canada; Daniel Ricciuto, MD, Lakeridge Health, Oshawa, Ontario, Canada; Anu Rebbapragada, PhD, Dynacare, Toronto, Ontario, Canada; Alicia Sarabia, MD, Trillium Health Partners, Mississauga, Ontario, Canada; Andrew Simor, MD, Sunnybrook Health Sciences Center, Toronto, Ontario, Canada.
*
Author for correspondence: Allison J. McGeer, Email: allison.mcgeer@sinaihealthsystem.ca
Get access Rights & Permissions [Opens in a new window]

Abstract

Objective:

To determine infection prevention and control (IPAC) practices for carbapenemase-producing Enterobacteriaceae (CPE), an emerging threat, at acute-care hospitals in Ontario, Canada.

Design:

A descriptive cross-sectional survey.

Methods:

We surveyed IPAC directors and managers at all acute-care hospitals in Ontario, Canada, to gather information on IPAC practices related to CPE, including admission screening, other patient screening, environmental testing, use of precautions to prevent transmission, and outbreak management.

Results:

Of 116 acute-care hospitals, 105 (91%) responded. Admission screening included patients previously colonized or infected with CPE (n = 64, 61%), patients recently hospitalized outside of Canada (Indian subcontinent, n = 62, 59%; other countries, n = 56, 53%), and patients recently hospitalized in Canada (n = 22, 21%). Fifty-one hospitals (49%) screened patients for colonization during an outbreak. Almost all hospitals (n = 101, 96%) used precautions to prevent transmission from patients with CPE colonization or infection; most hospitals (n = 54, 53%) continued precautions indefinitely. Few hospitals (n = 19, 18%) performed environmental cultures. Eight hospitals (8%) reported at least 1 outbreak, and 6 hospitals (6%) reported transmission from sink or shower drains to patients.

Conclusions:

Variability in practices may result from lack of evidence and challenges in updating guidelines as evidence emerges. A coordinated approach to slow the emergence of CPE should be considered in our population.

Type
Original Article
Information
Infection Control & Hospital Epidemiology , Volume 40 , Issue 9 , September 2019 , pp. 1006 - 1012
Copyright
© 2019 by The Society for Healthcare Epidemiology of America. All rights reserved. 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Pillai, DR, Melano, RG Rawte, P, et al. Klebsiella pneumoniae carbapenemase, Canada. Emerg Infect Dis 2009;15:828–829.CrossRefGoogle Scholar
Kus, JV, Tadros, M, Simor, A, et al. New Delhi metallo-beta-lactamase-1: local acquisition in Ontario, Canada, and challenges in detection. CMAJ 2011;183(11):1–5.CrossRefGoogle ScholarPubMed
Borgia, S, Lastovetska, O, Richardson, D, et al. Outbreak of carbapenem-resistant enterobacteriaceae containing blaNDM-1, Ontario, Canada. Clin Infect Dis 2012;55(11):e109–e117.CrossRefGoogle ScholarPubMed
Tijet, N, Muller, MP, Matukas, LM Khan, A, Patel, SN, Melano, RG. Lateral dissemination and interpatient transmission of blaKPC-3: role of a conjugative plasmid in spreading carbapenem resistance. J Antimicrob Chemother 2016;71:344–347.CrossRefGoogle Scholar
Leung, V, Loo, VG, Frenette, C, et al. First Canadian outbreak of Enterobacteriaceae-expressing Klebsiella pneumoniae carbapenemase type 3. Can J Infect Dis Med Microbiol 2012;23:117–120.CrossRefGoogle ScholarPubMed
Goldfarb, D, Harvey, SB, Jessamine, K, Jessamine, P, Toye, B, Desjardins, M. Detection of plasmid-mediated KPC-producing Klebsiella pneumoniae in Ottawa, Canada: evidence of intrahospital transmission. J Clin Microbiol 2009;47:1920–1922.CrossRefGoogle ScholarPubMed
Public Health Agency of Canada. Canadian Antimicrobial Resistance Surveillance System 2017 Report. https://www.canada.ca/en/public-health/services/publications/drugs-health-products/canadian-antimicrobial-resistance-surveillance-system-2017-report-executive-summary.html. Published 2018. Accessed January 3, 2019.Google Scholar
Zhong, Z, Faheem, A, Farooqi, L, et al. Emergence of carbapenemase-producing Enterobacteriaceae in south central Ontario, Canada. In: Abstracts of the Infectious Diseases Society of America IDWeek2018; 2018 October 3–7; San Francisco, California. Abstract 1205. https://idsa.confex.com/idsa/2018/webprogram/Paper69421.html.Google Scholar
Kohler, PP, Melano, RG, Patel, SN, et al. Emergence of carbapenemase-producing Enterobacteriaceae, south central Ontario, Canada. Emerg Infect Dis 2018;24:1674–1682.CrossRefGoogle Scholar
Provincial Infectious Diseases Advisory Committee. Screening, testing and surveillance for antibiotic-resistant organisms (AROs) in all health care settings. Public Health Ontario website. https://www.publichealthontario.ca/en/eRepository/PIDAC-IPC_Annex_A_Screening_Testing_Surveillance_AROs_2013.pdf. Published 2013. Accessed January 3, 2019.Google Scholar
Public Health Agency of Canada. Guidance: infection prevention and control measures for healthcare workers in all healthcare settings: carbapenem-resistant gram-negative bacilli. Public Health Agency of Canada website. http://www.phac-aspc.gc.ca/nois-sinp/guide/ipcm-mpci/pdf/guide-eng.pdf. Published 2010. Accessed January 3, 2019.Google Scholar
Facility guidance for control of carbapenem-resistant Enterobacteriaceae (CRE). Centers for Disease Control and Prevention website. https://www.cdc.gov/hai/pdfs/cre/CRE-guidance-508.pdf. Published 2015. Accessed January 3, 2019.Google Scholar
Carmeli, Y, Akova, M, Cornaglia, G, et al. Controlling the spread of carbapenemase-producing gram-negatives: therapeutic approach and infection control. Clin Microbiol Infect 2010;16:102–111.CrossRefGoogle ScholarPubMed
Gupta, N, Limbago, BM, Patel, JB, Kallen, AJ. Carbapenem-resistant Enterobacteriaceae: epidemiology and prevention. Clin Infect Dis 2011;53:60–67.CrossRefGoogle Scholar
Schwaber, MJ, Lev, B, Israeli, A, et al. Containment of a country-wide outbreak of carbapenem-resistant Klebsiella pneumoniae in Israeli hospitals via a nationally implemented intervention. Clin Infect Dis 2011;52:848–855.CrossRefGoogle Scholar
Jamal, AJ, Armstrong, I, Burgundvaag, E, et al. Variation in hospital control programs for carbapenemase-producing Enterobacteriaceae (CPE) in Ontario, Canada. In: Abstracts of the 28th European Congress of Clinical Microbiology & Infectious Diseases; 2018 April 21–24; Madrid, Spain. Abstract P1028. https://www.escmid.org/escmid_publications/escmid_elibrary/?q%3Djamal+cpe%26id%3D2173%26L%3D0%26x%3D0%26y%3D0.Google Scholar
Sekirov, I, Croxen, MA, Ng, C, et al. Epidemiologic and genotypic review of carbapenemase-producing organisms in British Columbia, Canada, between 2008 and 2014. J Clin Microbiol 2016;54:317–327.Google ScholarPubMed
Lapointe-Shaw, L, Voruganti, T, Kohler, P, Thein, HH, Sander, B, McGeer, A. Cost-effectiveness analysis of universal screening for carbapenemase-producing Enterobacteriaceae in hospital inpatients. Eur J Clin Microbiol Infect Dis 2017;36:1047–1055.CrossRefGoogle ScholarPubMed
Ho, K, Ng, W, Ip, M, You, JHS. Active surveillance of carbapenem-resistant Enterobacteriaceae in intensive care units: is it cost-effective in a nonendemic region? Am J Infect Control 2016;44:394–399.CrossRefGoogle Scholar
Systematic review of the effectiveness of infection control measures to prevent the transmission of carbapenemase-producing Enterobacteriaceae through cross-border transfer of patients. European Centre for Disease Prevention and Control website. https://ecdc.europa.eu/sites/portal/files/media/en/publications/Publications/CPE-systematic-review-effectiveness-infection-control-measures-to-prevent-transmission-2014.pdf. Published 2014. Accessed January 3, 2019.Google Scholar
Donker, T, Henderson, KL, Hopkins, KL, et al. The relative importance of large problems far away versus small problems closer to home: insights into limiting the spread of antimicrobial resistance in England. BMC Med 2017;15:1–11.Google ScholarPubMed
Tran, K, Bell, C, Stall, N, et al. The effect of hospital isolation precautions on patient outcomes and cost of care: a multi-site, retrospective, propensity score-matched cohort study. J Gen Intern Med 2017;32:262–268.CrossRefGoogle ScholarPubMed
Morgan, D, Diekema, D, Sepkowitz, K, Perencevich, E. Adverse outcomes associated with contact precautions: a review of the literature. Am J Infect Control 2013;37:85–93.CrossRefGoogle Scholar
Mehrotra, P, Croft, L, Day, HR, et al. Effects of contact precautions on patient perception of care and satisfaction: a prospective cohort study. Infect Control Hosp Epidemiol 2014;34: 1987–1093.Google Scholar
Dashiell-Earp, C, Bell, D, Ang, A, Uslan, D. Do physicians spend less time with patients in contact isolation? A time-motion study of internal medicine interns. JAMA Intern Med 2014;174:814–815.CrossRefGoogle ScholarPubMed
Lowe, CF, Kus, JV, Salt, N, et al. Nosocomial transmission of New Delhi metallo-β-lactamase-1–producing Klebsiella pneumoniae in Toronto, Canada. Infect Control Hosp Epidemiol 2013;34:49–55.CrossRefGoogle ScholarPubMed
Kizny Gordon, AE, Mathers, AJ, Cheong, EYL, et al. The hospital water environment as a reservoir for carbapenem-resistant organisms causing hospital-acquired infections—a systematic review of the literature. Clin Infect Dis 2017;64:1436–1444.Google ScholarPubMed
Kanamori, H, Weber, DJ, Rutala, WA. Healthcare outbreaks associated with a water reservoir and infection prevention strategies. Clin Infect Dis 2016;62:1423–1435.CrossRefGoogle ScholarPubMed
Johnson, RC, Deming, C, Conlan, S, et al. Investigation of a cluster of Sphingomonas koreensis infections. N Engl J Med 2018;379:2529–2539.CrossRefGoogle ScholarPubMed
Best practices for environmental cleaning for prevention and control of infections in all healthcare settings, 3rd edition. Public Health Ontario website. https://www.publichealthontario.ca/-/media/documents/bp-environmental-cleaning.pdf?la=en. Accessed May 3, 2019.Google Scholar
Appendix B: Provincial case definitions for reportable diseases. Disease: Carbapenemase-producing Enterobacteriaceae (CPE) infection or colonization. Ministry of Health and Long-Term Care, Government of Ontario website. http://www.health.gov.on.ca/en/pro/programs/publichealth/oph_standards/docs/CPE_cd.pdf. Accessed January 3, 2019.Google Scholar
Supplementary material: File

Jamal et al. supplementary material

Jamal et al. supplementary material 1

Download Jamal et al. supplementary material(File)
File 67.6 KB